Universitätsklinikum Ulm

Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 status (2021) Hein A, Hartkopf AD, Emons J, Lux MP, Volz B, Taran FA, Overkamp F, et al. Journal article Disseminated tumour cells from the bone marrow of early breast cancer patients: Results from an international pooled analysis (2021) Hartkopf AD, Brucker SY, Taran FA, Harbeck N, von Au A, Naume B, Pierga JY, et al. Journal article Full or intensity-reduced high-dose melphalan and single or double autologous stem cell transplant with or without bortezomib consolidation in patients with newly diagnosed multiple myeloma (2021) Straka C, Salwender H, Knop S, Vogel M, Muller J, Metzner B, Langer C, et al. Journal article Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment (2021) Morra A, Escala-Garcia M, Beesley J, Keeman R, Canisius S, Ahearn TU, Andrulis IL, et al. Journal article Biographical Feature: Bernhard Fleckenstein (2021) Thoma-Kreß A, Desrosiers RC, Gack MU, Jung JU, Überla K, Kirchhoff F Journal article Degarelix for treating advanced hormone-sensitive prostate cancer (2021) Zengerling F, Jakob JJ, Schmidt S, Meerpohl JJ, Blumle A, Schmucker C, Mayer B, Kunath F Journal article Comment on the guidelines (2020) of the ESC on sports cardiology and exercise in patients with cardiovascular disease Kommentar zu den Leitlinien (2020) der ESC zu Sportkardiologie und körperlichem Training für Patienten mit kardiovaskulären Erkrankungen (2021) Halle M, Burgstahler C, Gielen S, Hambrecht R, Laszlo R, Tiefenbacher C Journal article, Review article Caesarean Section. Guideline of the DGGG, OEGGG and SGGG (S3-Level, AWMF Registry No. 015/084, June 2020) (2021) Louwen F, Wagner U, Abou-Dakn M, Doetsch J, Lawrenz B, Ehm D, Surbek D, et al. Journal article, Review article Empfehlungen für die strukturellen Voraussetzungen der perinatologischen Versorgung in Deutschland (Entwicklungsstufe S2k, AWMF-Leitlinien-Register Nr087-001, März 2021) (2021) Rossi R, Bauer NH, Becke-Jakob K, Grab D, Herting E, Mitschdoerfer B, Olbertz DM, et al. Journal article, Review article Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials (2021) Denkert C, Seither F, Schneeweiss A, Link T, Blohmer JU, Just M, Wimberger P, et al. Journal article